Learn About Hypersensitivity Vasculitis

What is the definition of Hypersensitivity Vasculitis?

Hypersensitivity vasculitis is an extreme reaction to a drug, infection, or foreign substance. It leads to inflammation and damage to blood vessels, mainly in the skin. The term is not used much currently because more specific names are considered more precise.

What are the alternative names for Hypersensitivity Vasculitis?

Cutaneous small vessel vasculitis; Allergic vasculitis; Leukocytoclastic vasculitis

What are the causes of Hypersensitivity Vasculitis?

Hypersensitivity vasculitis, or cutaneous small vessel vasculitis, is caused by:

  • An allergic reaction to a drug or other foreign substance
  • A reaction to an infection

It usually affects people older than age 16.

Often, the cause of the problem cannot be found even with a careful study of the person's medical history.

Hypersensitivity vasculitis may look like systemic, necrotizing vasculitis, which can affect blood vessels throughout the body and not just in the skin. In children, it can look like Henoch-Schonlein purpura.

What are the symptoms of Hypersensitivity Vasculitis?

Symptoms may include:

  • New rash with tender, purple or brownish-red spots over large areas
  • Skin sores mostly located on the legs, buttocks, or trunk
  • Blisters on the skin
  • Hives (urticaria), may last longer than 24 hours
  • Open sores with dead tissue (necrotic ulcers)
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hypersensitivity Vasculitis?

The goal of treatment is to reduce inflammation.

Your provider may prescribe aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or corticosteroids to reduce inflammation of the blood vessels. (Do not give aspirin to children except as advised by your provider).

Your provider will tell you to stop taking medicines that could be causing this condition.

Who are the top Hypersensitivity Vasculitis Local Doctors?

New York Society For The Relief Of Ruptured And Crippled Maintaining

535 E 70th St, Hss Department Of Medicine, 
New York, NY 
 (4.3 mi)
Experience:
17+ years
Languages Spoken:
English
Offers Telehealth

Lindsay Lally is a Rheumatologist in New York, New York. Dr. Lally has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Hypersensitivity Vasculitis. Her top areas of expertise are Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Temporal Arteritis, and Giant Cell Arteritis (GCA).

Rheumatology
Rheumatology

Advantagecare Physicians PC

101 Pennsylvania Ave, 
Brooklyn, NY 
 (4.5 mi)
Languages Spoken:
English

King Goh is a Rheumatologist in Brooklyn, New York. Dr. Goh and is rated as an Advanced provider by MediFind in the treatment of Hypersensitivity Vasculitis. His top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis.

 
 
 
 
Learn about our expert tiers
Learn More
Rheumatology
Rheumatology

New York Society For The Relief Of Ruptured And Crippled Maintaining

535 E 70th St, Hss Department Of Medicine, 
New York, NY 
 (4.3 mi)
Experience:
40+ years
Languages Spoken:
English
Offers Telehealth

Anne Bass is a Rheumatologist in New York, New York. Dr. Bass has been practicing medicine for over 40 years and is rated as an Experienced provider by MediFind in the treatment of Hypersensitivity Vasculitis. Her top areas of expertise are Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Rheumatoid Arthritis (RA), Knee Replacement, and Hip Replacement.

What is the outlook (prognosis) for Hypersensitivity Vasculitis?

Hypersensitivity vasculitis most often goes away over time. The condition may come back in some people.

People with ongoing vasculitis should be checked for systemic vasculitis.

What are the possible complications of Hypersensitivity Vasculitis?

Complications may include:

  • Lasting damage to the blood vessels or skin with scarring
  • Inflamed blood vessels affecting the internal organs
When should I contact a medical professional for Hypersensitivity Vasculitis?

Contact your provider if you have symptoms of hypersensitivity vasculitis.

How do I prevent Hypersensitivity Vasculitis?

Do not take medicines that have caused an allergic reaction in the past.

What are the latest Hypersensitivity Vasculitis Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
What are the Latest Advances for Hypersensitivity Vasculitis?
A Case of Skin Limited IgA Vasculitis in an 84-Year-Old Female.
Urticarial vasculitis.
Tired of the same old research?
Check Latest Advances
Who are the sources who wrote this article ?

Published Date: April 30, 2023
Published By: Neil J. Gonter, MD, Assistant Professor of Medicine, Columbia University, New York, NY, and private practice specializing in Rheumatology at Rheumatology Associates of North Jersey, Teaneck, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Dinulos JGH. Hypersensitivity syndromes and vasculitis. In: Dinulos JGH, ed. Habif's Clinical Dermatology. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 18.

Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1-11. PMID: 23045170 pubmed.ncbi.nlm.nih.gov/23045170/.

Patterson JW. The vasculopathic reaction pattern. In: Patterson JW, ed. Weedon's Skin Pathology. 5th ed. Philadelphia, PA: Elsevier; 2021:chap 9.

Stone JH. The systemic vasculitides. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 254.

Sunderkötter CH, Zelger B, Chen KR, et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol. 2018;70(2):171-184. PMID: 29136340 pubmed.ncbi.nlm.nih.gov/29136340/.